Title : Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma.

Pub. Date : 2012 Jul

PMID : 22414760






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma. Sorafenib alpha fetoprotein Homo sapiens
2 METHODS: In HCC patients treated with sorafenib with baseline AFP >20 ng/ml, AFP response was defined as a >20% decrease in AFP during 8weeks of treatment. Sorafenib alpha fetoprotein Homo sapiens
3 METHODS: In HCC patients treated with sorafenib with baseline AFP >20 ng/ml, AFP response was defined as a >20% decrease in AFP during 8weeks of treatment. Sorafenib alpha fetoprotein Homo sapiens
4 METHODS: In HCC patients treated with sorafenib with baseline AFP >20 ng/ml, AFP response was defined as a >20% decrease in AFP during 8weeks of treatment. Sorafenib alpha fetoprotein Homo sapiens